Dr. Jasjit Bhinder, M.D
NPI: 1730523077
Total Payments
$52,569
2024 Payments
$708.05
Companies
13
Transactions
33
Medicare Patients
705
Medicare Billing
$141,284
Payment Breakdown by Category
Research$50,925 (96.9%)
Food & Beverage$1,630 (3.1%)
Education$13.89 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $50,925 | 10 | 96.9% |
| Food and Beverage | $1,630 | 22 | 3.1% |
| Education | $13.89 | 1 | 0.0% |
Payments by Type
Research
$50,925
10 transactions
General
$1,644
23 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $50,925 | 10 | $0 (2023) |
| Abbott Laboratories | $312.80 | 3 | $0 (2024) |
| Impulse Dynamics (USA) Inc. | $271.04 | 2 | $0 (2022) |
| Lexicon Pharmaceuticals, Inc. | $231.76 | 4 | $0 (2024) |
| CVRx, Inc. | $189.15 | 2 | $0 (2023) |
| E.R. Squibb & Sons, L.L.C. | $166.38 | 3 | $0 (2024) |
| Philips North America LLC | $112.69 | 1 | $0 (2024) |
| Merck Sharp & Dohme LLC | $109.96 | 1 | $0 (2024) |
| ABIOMED | $108.34 | 1 | $0 (2024) |
| Alnylam Pharmaceuticals Inc. | $56.90 | 2 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $708.05 | 12 | Lexicon Pharmaceuticals, Inc. ($205.04) |
| 2023 | $8,864 | 8 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($8,475) |
| 2022 | $20,215 | 10 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($19,800) |
| 2021 | $22,782 | 3 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($22,650) |
All Payment Transactions
33 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/16/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $97.19 | General |
| 06/01/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $76.92 | General |
| 05/29/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $26.95 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/23/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $50.53 | General |
| Category: Heart Failure | ||||||
| 05/09/2024 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $108.34 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | Merck Sharp & Dohme LLC | VERQUVO (Drug), VERQUVO | Food and Beverage | In-kind items and services | $109.96 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/01/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $27.47 | General |
| Category: Genetic Disease | ||||||
| 04/15/2024 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $29.43 | General |
| Category: Genetic Disease | ||||||
| 04/04/2024 | Lexicon Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $30.93 | General |
| 03/27/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.56 | General |
| Category: Cardiovascular | ||||||
| 02/07/2024 | Philips North America LLC | (AO0) IGT Devices Intracardiac (Device) | Food and Beverage | Cash or cash equivalent | $112.69 | General |
| Category: Medical Device | ||||||
| 12/13/2023 | Lexicon Pharmaceuticals, Inc. | Inpefa (Drug) | Food and Beverage | In-kind items and services | $26.72 | General |
| Category: Inhibitor of SGLT2 and SGLT1 | ||||||
| 12/12/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $23.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/18/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | — | Cash or cash equivalent | $7,875.00 | Research |
| Study: BMAD • Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 06/14/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $40.31 | General |
| Category: Heart Failure and Hypertension | ||||||
| 06/07/2023 | CVRx, Inc. | Barostim Neo System (Device) | Food and Beverage | Cash or cash equivalent | $148.84 | General |
| Category: Heart Failure and Hypertension | ||||||
| 04/19/2023 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | — | Cash or cash equivalent | $600.00 | Research |
| Study: BMAD • Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $133.27 | General |
| Category: Cardiovascular | ||||||
| 04/18/2023 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.55 | General |
| Category: Cardiovascular | ||||||
| 10/19/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Education | In-kind items and services | $13.89 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/12/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | — | Cash or cash equivalent | $1,500.00 | Research |
| Study: BMAD • Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 10/05/2022 | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | LifeVest (Device) | — | Cash or cash equivalent | $750.00 | Research |
| Study: BMAD • Category: Electromedical and Electrotherapeutic Apparatus | ||||||
| 09/28/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $137.27 | General |
| Category: Heart Failure | ||||||
| 09/26/2022 | Abbott Laboratories | THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Heart Failure | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| BMAD | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $48,450 | 9 |
| HF OPT | ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $2,475 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 267 | 551 | $258,413 | $43,353 |
| 2022 | 7 | 347 | 661 | $383,589 | $74,743 |
| 2021 | 3 | 91 | 207 | $109,140 | $23,188 |
Total Patients
705
Total Services
1,419
Medicare Billing
$141,284
Procedure Codes
16
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 92 | 252 | $81,144 | $16,535 | 20.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 66 | 111 | $76,479 | $11,163 | 14.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 62 | 64 | $56,256 | $9,211 | 16.4% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2023 | 17 | 93 | $25,203 | $3,960 | 15.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 14 | 14 | $16,968 | $2,271 | 13.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 16 | 17 | $2,363 | $212.33 | 9.0% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 122 | 367 | $168,820 | $34,763 | 20.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 89 | 94 | $82,626 | $17,377 | 21.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 63 | 94 | $64,766 | $11,139 | 17.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 31 | 31 | $37,572 | $6,564 | 17.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 16 | 16 | $15,664 | $2,581 | 16.5% |
| 93264 | Remote monitoring of pulmonary artery pressure sensor, up to 30 days | Office | 2022 | 13 | 45 | $12,195 | $2,123 | 17.4% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 13 | 14 | $1,946 | $196.70 | 10.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 53 | 169 | $77,740 | $16,385 | 21.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 24 | $21,096 | $4,523 | 21.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $10,304 | $2,281 | 22.1% |
About Dr. Jasjit Bhinder, M.D
Dr. Jasjit Bhinder, M.D is a Advanced Heart Failure and Transplant Cardiology healthcare provider based in Poughkeepsie, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2013. The National Provider Identifier (NPI) number assigned to this provider is 1730523077.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jasjit Bhinder, M.D has received a total of $52,569 in payments from pharmaceutical and medical device companies, with $708.05 received in 2024. These payments were reported across 33 transactions from 13 companies. The most common payment nature is "" ($50,925).
As a Medicare-enrolled provider, Bhinder has provided services to 705 Medicare beneficiaries, totaling 1,419 services with total Medicare billing of $141,284. Data is available for 3 years (2021–2023), covering 16 distinct procedure/service records.
Ad
Practice Information
- Specialty Advanced Heart Failure and Transplant Cardiology
- Location Poughkeepsie, NY
- Active Since 04/17/2013
- Last Updated 07/30/2025
- Taxonomy Code 207RA0001X
- Entity Type Individual
- NPI Number 1730523077
Products in Payments
- LifeVest (Device) $50,925
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT (Device) $262.27
- Barostim Neo System (Device) $189.15
- CAMZYOS (Drug) $166.38
- Optimizer (Device) $139.15
- Optimizer Smart System (Device) $131.89
- (AO0) IGT Devices Intracardiac (Device) $112.69
- VERQUVO (Drug) $109.96
- Impella (Device) $108.34
- AMVUTTRA (Drug) $56.90
- CARDIOMEMS (Device) $50.53
- ENTRESTO (Drug) $26.95
- Inpefa (Drug) $26.72
- LEQVIO (Drug) $23.31
- NEXLETOL (Drug) $21.08
- FARXIGA (Drug) $13.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.